Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Applied Health Economics and Health Policy
Published in: Applied Health Economics and Health Policy 2/2016

01-04-2016 | Systematic Review

A Systematic Review of the Literature on the Development of Condition-Specific Preference-Based Measures of Health

Authors: Elizabeth Goodwin, Colin Green

Published in: Applied Health Economics and Health Policy | Issue 2/2016

Login to get access

Abstract

Background

Health state utility values (HSUVs) are required to calculate quality-adjusted life-years (QALYs). They are frequently derived from generic preference-based measures of health. However, such generic measures may not capture health attributes of relevance to specific conditions. In such cases, a condition-specific preference-based measure (CSPBM) may be more appropriate.

Objective

This systematic review aimed to identify all published accounts of developing CSPBMs to describe and appraise the methods used.

Method

We undertook a systematic search (of Embase, MEDLINE, PsycINFO, Web of Science, the Cochrane Library, CINAHL, EconLit, ASSIA and the Health Management Information Consortium database) to identify published accounts of CSPBM development up to July 2015. Studies were reviewed to investigate the methods used to design classification systems, estimate HSUVs, and validate the measures.

Results

A total of 86 publications were identified, describing 51 CSPBMs. Around two-thirds of these were QALY measures; the remainder were designed for clinical decision making only. Classification systems for 33 CSPBMs were derived from existing instruments; 18 were developed de novo. HSUVs for 34 instruments were estimated using a ‘composite’ approach, involving statistical modelling; the remainder used a ‘decomposed’ approach based on multi-attribute utility theory. Half of the papers that described the estimation of HSUVs did not report validating their measures.

Conclusion

Various methods have been used at all stages of CSPBM development. The choice between developing a classification system de novo or from an existing instrument may depend on the availability of a suitable existing measure, while the choice between a decomposed or composite approach appears to be determined primarily by the purpose for which the instrument is designed. The validation of CSPBMs remains an area for further development.
Appendix
Available only for authorised users
Footnotes
1
Unlike traditional psychometric approaches, Rasch models produce interval scales that are based on an estimate of the true score rather than relying on observed scores. Item parameters are estimated independently of the sample used for scale construction; similarly, person values are estimated independently of the items used. This avoids two limitations of traditional psychometric methods, in which results for scales are sample dependent and vice versa. Rasch models are more tolerant of missing data and do not require imputation of missing values [94].
 
Literature
1.
Brazier JE, Rowen D, Mavranezouli I, Tsuchiya A, Young T, Yang Y, Barkham M, Ibbotson R. Developing and testing methods for deriving preference-based measures of health from condition-specific measures (and other patient-based measures of outcome). Health Technol Assess. 2012;16(32):1–114.CrossRef
2.
3.
Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ. 2002;21:271–92.CrossRefPubMed
4.
Horsman J, Furlong W, Feeny D, Torrance G. The Health Utilities Index (HUI): concepts, measurement properties and applications. Health Qual Life Outcomes. 2003;1:54.CrossRefPubMedPubMedCentral
5.
Brazier J, Ratcliffe J, Salomon J, Tsuchiya A. Measuring and valuing health benefits for economic evaluation. Oxford: Oxford University Press; 2007.
6.
Feeny D. The multi-attribute utility approach to assessing health-related quality of life. In: Jones A, editor. The Elgar companion to health economics. Cheltenham: Edward Elgar; 2006. p. 359–70.
7.
Mortimer D, Segal L. Comparing the incomparable? A systematic review of competing techniques for converting descriptive measures of health status into QALY-weights. Med Decis Mak. 2008;28(1):66–89.CrossRef
8.
Petrillo J, Cairns J. Converting condition-specific measures into preference-based outcomes for use in economic evaluation. Expert Rev Pharmacoecon Outcomes Res. 2008;8(5):453–61.CrossRefPubMed
9.
Lin F-J, Longworth L, Pickard A. Evaluation of content on EQ-5D as compared to disease-specific utility measures. Qual Life Res. 2013;22(4):853–74.CrossRefPubMed
10.
Bellamy CA, Brickley MR, McAndrew R. Measurement of patient-derived utility values for periodontal health using a multi-attribute scale. J Clin Periodontol. 1996;23(9):805–9.CrossRefPubMed
11.
Beusterien K, Leigh N, Jackson C, Miller R, Mayo K, Revicki D. Integrating preferences into health status assessment for amyotrophic lateral sclerosis: The ALS Utility Index. Amyotroph Lateral Scler Other Motor Neuron Disord. 2005;6(3):169–76.CrossRefPubMed
12.
Brazier JE, Roberts J, Platts M, Zoellner YF. Estimating a preference-based index for a menopause specific health quality of life questionnaire. Health Qual Life Outcomes. 2005;3:13.CrossRefPubMedPubMedCentral
13.
Brazier J, Czoski-Murray C, Roberts J, Brown M, Symonds T, Kelleher C. Estimation of a preference-based index from a condition-specific measure: the King’s Health Questionnaire. Med Dec Mak. 2008;28(1):113–26.CrossRef
14.
Burr JM, Kilonzo M, Vale L, Ryan M. Developing a preference-based glaucoma utility index using a discrete choice experiment. Optom Vis Sci. 2007;84(8):797–808.CrossRefPubMed
15.
Chiou CF, Weaver MR, Bell MA, Lee TA, Krieger JW. Development of the multi-attribute pediatric asthma health outcome measure (PAHOM). Int J Qual Health Care. 2005;17(1):23–30.CrossRefPubMed
16.
Cho S, Kim H, Kim SH, Ock M, Oh YM, Jo MW. Utility estimation of hypothetical chronic obstructive pulmonary disease health states by the general population and health professionals. Health Qual Life Outcomes. 2015;13:34.CrossRefPubMedPubMedCentral
17.
Cuervo J, Castejón N, Khalaf KM, Waweru C, Globe D, Patrick DL. Development of the Incontinence Utility Index: estimating population-based utilities associated with urinary problems from the Incontinence Quality of Life Questionnaire and Neurogenic Module. Health Qual Life Outcomes. 2014;12:147.CrossRefPubMedPubMedCentral
18.
Dobrez D, Cella D, Pickard AS, Lai JS, Nickolov A. Estimation of patient preference-based utility weights from the Functional Assessment of Cancer Therapy—General. Value Health. 2007;10(4):266–72.CrossRefPubMed
19.
Hess LM, Brady WE, Havrilesky LJ, Cohn DE, Monk BJ, Wenzel L, et al. Comparison of methods to estimate health state utilities for ovarian cancer using quality of life data: a Gynecologic Oncology Group study. Gynecol Oncol. 2013;128(2):175–80.CrossRefPubMedPubMedCentral
20.
Pickard AS, Ray S, Ganguli A, Cella D. Comparison of FACT- and EQ-5D-based utility scores in cancer. Value Health. 2012;15(2):305–11.CrossRefPubMed
21.
Goodey RD, Brickley MR, Armstrong RA, Shepherd JP. The minor oral surgery outcome scale: a multi-attribute patient-derived outcome measure. J Oral Maxillofac Surg. 2000;58(10):1096–101.CrossRefPubMed
22.
Goodwin E, Green C. A quality-adjusted life-year measure for multiple sclerosis: developing a patient-reported health state classification system for a multiple sclerosis-specific preference-based measure. Value Health. 2015;18(8):1016–24.CrossRefPubMed
23.
Goodwin E, Green C, Spencer A. Estimating a preference-based index for an eight dimensional health state classification system derived from the Multiple Sclerosis Impact Scale (MSIS-29). Value Health. 2015;18(8):1025–36.CrossRef
24.
Gu NY, Botteman MF, Gerber RA, Ji X, Postema R, Wan Y, Sianos G, Anthony I, Cappelleri JC, Szczypa P, van Hout B. Eliciting health state utilities for Dupuytren’s contracture using a discrete choice experiment. Acta Orthop. 2013;84(6):571–8.CrossRefPubMedPubMedCentral
25.
Hauber AB, Mohamed AF, Johnson FR, Oyelowo O, Curtis BH, Coon C. Estimating importance weights for the IWQOL-Lite using conjoint analysis. Qual Life Res. 2010;19(5):701–9.CrossRefPubMed
26.
Mohamed AF, Hauber AB, Johnson FR, Coon CD. Patient preferences and linear scoring rules for patient-reported outcomes. Patient. 2010;3(4):217–27.CrossRefPubMed
27.
Hodder SC, Edwards MJ, Brickley MR, Shepherd JP. Multiattribute utility assessment of outcomes of treatment for head and neck cancer. Br J Cancer. 1997;75(6):898–902.CrossRefPubMedPubMedCentral
28.
Johnson FR, Hauber AB, Osoba D, Hsu MA, Coombs J, Copley-Merriman C. Are chemotherapy patients’ HRQoL importance weights consistent with linear scoring rules? A stated-choice approach. Qual Life Res. 2006;15(2):285–98.CrossRefPubMed
29.
Osoba D, Hsu M-A, Copley-Merriman C, Coombs J, Johnson FR, Hauber B, Manjunath R, Pyles A. Stated preferences of patients with cancer for health-related quality-of-life (HRQOL) domains during treatment. Qual Life Res. 2006;15:273–83.CrossRefPubMed
30.
Kerr C, Breheny K, Lloyd A, Brazier J, Bailey DB, Berry-Kravis E, Cohen J, Petrillo J. Developing a utility index for the Aberrant Behavior Checklist (ABC-C) for fragile X syndrome. Qual Life Res. 2015;24(2):305–14.CrossRefPubMedPubMedCentral
31.
Kind P, Macran S. Eliciting social preference weights for Functional Assessment of Cancer Therapy-Lung health states. PharmacoEconomics. 2005;23(11):1143–53.CrossRefPubMed
32.
Lamers LM, Uyl-de Groot CA, Buijt I. The use of disease-specific outcome measures in cost-utility analysis: the development of Dutch societal preference weights for the FACT-L scale. PharmacoEconomics. 2007;25(7):591–603.CrossRefPubMed
33.
Kok ET, McDonnell J, Stolk EA, Stoevelaar HJ, Busschbach JJV. The valuation of the International Prostate Symptom Score (IPSS) for use in economic evaluations. Eur Urol. 2002;42(5):491–7.CrossRefPubMed
34.
Kowalski JW, Rentz AM, Walt JG, Lloyd A, Lee J, Young TA, et al. Rasch analysis in the development of a simplified version of the National Eye Institute Visual-Function Questionnaire-25 for utility estimation. Qual Life Res. 2012;21(2):323–34.CrossRefPubMed
35.
Rentz AM, Kowalski JW, Walt JG, Hays RD, Brazier JE, Yu R, Lee P, Bressler N, Revicki DA. Development of a preference-based index from the National Eye Institute Visual Function Questionnaire-25. JAMA Ophthalmol. 2014;132(3):310–8.CrossRefPubMedPubMedCentral
36.
Naik RK, Gries KS, Rentz AM, Kowalski JW, Revicki DA. Psychometric evaluation of the National Eye Institute Visual Function Questionnaire and Visual Function Questionnaire Utility Index in patients with non-infectious intermediate and posterior uveitis. Qual Life Res. 2013;22(10):2801–8.CrossRefPubMed
37.
Krahn M, Ritvo P, Irvine J, Tomlinson G, Bezjak A, Trachtenberg J, et al. Construction of the Patient-Oriented Prostate Utility Scale (PORPUS): a multiattribute health state classification system for prostate cancer. J Clin Epidemiol. 2000;53(9):920–30.CrossRefPubMed
38.
Ritvo P, Irvine J, Naglie G, Tomlinson G, Bezjak A, Matthew A, et al. Reliability and validity of the PORPUS, a combined psychometric and utility-based quality-of-life instrument for prostate cancer. J Clin Epidemiol. 2005;58(5):466–74.CrossRefPubMed
39.
Tomlinson G, Bremner KE, Ritvo P, Naglie G, Krahn MD. Development and validation of a utility weighting function for the Patient-Oriented Prostate Utility Scale (PORPUS). Med Decis Mak. 2012;32(1):11–30.CrossRef
40.
Avila M, Pardo Y, Castells M, Ferrer F, On behalf of The Multicentric Spanish Group of Clinically Localized Prostate Cancer, et al. Adaptation and validation of the Spanish version of the Patient-Oriented Prostate Utility Scale (PORPUS). Qual Life Res. 2014;23(9):2481–2487.
41.
Kuspinar A, Finch L, Pickard S, Mayo NE. Using existing data to identify candidate items for a health state classification system in multiple sclerosis. Qual Life Res. 2014;23(5):1445–57.CrossRefPubMed
42.
Lloyd A, Kerr C, Breheny K, Brazier J, Ortiz A, Borg E. Economic evaluation in short bowel syndrome (SBS): an algorithm to estimate utility scores for a patient-reported SBS-specific quality of life scale (SBS-QoLTM). Qual Life Res. 2014;23(2):449–58.CrossRefPubMed
43.
Martin AJ, Glasziou PP, Simes RJ. A cardiovascular extension of the Health Measurement Questionnaire. J Epidemiol Community Health. 1999;53(9):548–57.CrossRefPubMedPubMedCentral
44.
Martin AJ, Glasziou PP, Simes RJ, Lumley T. Predicting patients’ utilities from quality of life items: an improved scoring system for the UBQ-H. Qual Life Res. 1998;7(8):703–11.CrossRefPubMed
45.
Mavranezouli I, Brazier JE, Young TA, Barkham M. Using Rasch analysis to form plausible health states amenable to valuation: the development of CORE-6D from a measure of common mental health problems (CORE-OM). Qual Life Res. 2011;20(3):321–33.CrossRefPubMed
46.
Mavranezouli I, Brazier JE, Rowen D, Barkham M. Estimating a preference-based index from the Clinical Outcomes in Routine Evaluation-Outcome Measure (CORE-OM): valuation of CORE-6D. Med Decis Mak. 2013;33(3):381–95.CrossRef
47.
McKenna SP, Ratcliffe J, Meads DM, Brazier JE. Development and validation of a preference based measure derived from the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) for use in cost utility analyses. Health Qual Life Outcomes. 2008;6:65.CrossRefPubMedPubMedCentral
48.
Misajon R, Hawthorne G, Richardson J, Barton J, Peacock S, Iezzi A, et al. Vision and quality of life: the development of a utility measure. Invest Ophthalmol Vis Sci. 2005;46(11):4007–15.CrossRefPubMed
49.
Peacock S, Misajon R, Iezzi A, Richardson J, Hawthorne G, Keeffe J. Vision and quality of life: development of methods for the VisQoL vision-related utility instrument. Ophthalmic Epidemiol. 2008;15(4):218–23.CrossRefPubMedPubMedCentral
50.
Finger RP, Kortuem K, Fenwick E, von Livonius B, Keeffe JE, Hirneiss CW. Evaluation of a vision-related utility instrument: the German Vision and Quality of Life Index. Invest Ophthalmol Vis Sci. 2013;54(2):1289–94.CrossRefPubMed
51.
Finger RP, Fenwick E, Hirneiss CW, Hsueh A, Guymer RH, Lamoureux EL, Jill E, Keeffe JE. Visual impairment as a function of visual acuity in both eyes and its impact on patient reported preferences. PLoS One. 2013;8:12.
52.
Gothwal VK, Bagga DK. Vision and Quality of Life Index: validation of the Indian version using Rasch analysis. Invest Ophthalmol Vis Sci. 2013;54(7):4871–81.CrossRefPubMed
53.
Gothwal VK, Bagga DK. Utility values in the visually impaired: comparing time-trade off and VisQoL. Optom Vis Sci. 2013;90(8):843–54.CrossRefPubMed
54.
Montejo AL, Correas-Lauffer J, Maurino J, Villa G, Rebollo P, Diez T, et al. Estimation of a multiattribute utility function for the Spanish Version of the TooL questionnaire. Value Health. 2011;14(4):564–70.CrossRefPubMed
55.
Mulhern B, Rowen D, Jacoby A, Marson T, Snape D, Hughes D, et al. The development of a QALY measure for epilepsy: NEWQOL-6D. Epilepsy Behav. 2012;24(1):36–43.CrossRefPubMed
56.
Mulhern B, Smith SC, Rowen D, Brazier JE, Knapp M, Lamping DL, et al. Improving the measurement of QALYs in dementia: developing patient- and carer-reported health state classification systems using Rasch analysis. Value Health. 2012;15(2):323–33.CrossRefPubMed
57.
Mulhern B, Rowen D, Brazier J, Smith S, Romeo R, Tait R, et al. Development of DEMQOL-U and DEMQOL-Proxy-U: generation of preference-based indices from DEMQOL and DEMQOL-Proxy for use in economic evaluation. Health Technol Assess. 2013;17(5):1–140.CrossRef
58.
Rowen D, Mulhern B, Banerjee S, Bv Hout, Young TA, Knapp M, et al. Estimating preference-based single index measures for dementia using DEMQOL and DEMQOL-Proxy. Value Health. 2012;15(2):346–56.CrossRefPubMed
59.
Palmer CS, Schmier JK, Snyder E, Scott B. Patient preferences and utilities for ‘off-time’ outcomes in the treatment of Parkinson’s disease. Qual Life Res. 2000;9(7):819–27.CrossRefPubMed
60.
Petrillo J, Cairns J. Development of the EXACT-U: a preference-based measure to report COPD exacerbation utilities. Value Health. 2011;14(4):546–54.CrossRefPubMed
61.
Petrillo J, Cairns J. Evaluation of COPD exacerbations using the EXACT-U. Barcelona: Annual European Respiratory Society Congress; 2010.
62.
Pickard AS, Shaw JW, Lin HW, Trask PC, Aaronson N, Lee TA, et al. A patient-based utility measure of health for clinical trials of cancer therapy based on the European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire. Value Health. 2009;12(6):977–88.CrossRefPubMed
63.
Poissant L, Mayo NE, Wood-Dauphinee S, Clarke AE. The development and preliminary validation of a Preference-Based Stroke Index (PBSI). Health Qual Life Outcomes. 2003;1:43.CrossRefPubMedPubMedCentral
64.
Ratcliffe J, Brazier J, Tsuchiya A, Symonds T, Brown M. Using DCE and ranking data to estimate cardinal values for health states for deriving a preference-based single index from the sexual quality of life questionnaire. Health Econ. 2009;18(11):1261–76.CrossRefPubMed
65.
Revicki DA, Leidy NK, Brennan-Diemer F, Sorensen S, Togias A. Integrating patient preferences into health outcomes assessment: the multiattribute Asthma Symptom Utility Index. Chest. 1998;114(4):998–1007.CrossRefPubMed
66.
Flood EM, De Cock E, Mork A-C, Revicki DA. Evaluating preference weights for the Asthma Symptom Utility Index (ASUI) across countries. Health Qual Life Outcomes. 2006;4:51.CrossRefPubMedPubMedCentral
67.
Bime C, Wei CY, Holbrook JT, Sockrider MM, Revicki DA, Wise RA. Asthma Symptom Utility Index: reliability, validity, responsiveness, and the minimal important difference in adult asthmatic patients. J Allergy Clin Immunol. 2012;130(5):1078–84.CrossRefPubMedPubMedCentral
68.
Revicki DA, Leidy NK, Brennan-Diemer F, Thompson C, Togias A. Development and preliminary validation of the multiattribute Rhinitis Symptom Utility Index. Qual Life Res. 1998;7(8):693–702.CrossRefPubMed
69.
Lo PSY, Tong MCF, Revicki DA, Lee CC, Woo JKS, Lam HCK, et al. Rhinitis Symptom Utility Index (RSUI) in Chinese subjects: a multiattribute patient-preference approach. Qual Life Res. 2006;15(5):877–87.CrossRefPubMed
70.
Revicki DA, Margolis MK, Thompson CL, Meltzer EO, Sandor DW, Shaw JW. Major Symptom Score Utility Index for patients with acute rhinosinusitis. Am J Rhinol. 2011;25(3):E99–106.CrossRef
71.
Rowen D, Brazier J, Young T, Gaugris S, Craig BM, King MT, et al. Deriving a preference-based measure for cancer using the EORTC QLQ-C30. Value Health. 2011;14(5):721–31.CrossRefPubMed
72.
Kularatna S, Whitty JA, Johnson NW, Jayasinghe R, Scuffham PA. Development of an EORTC-8D utility algorithm for Sri Lanka. Med Decis Mak. 2015;35(3):361–70.CrossRef
73.
Rowen D, Young T, Brazier J, Gaugris S. Comparison of generic, condition-specific, and mapped health state utility values for multiple myeloma cancer. Value Health. 2012;15(8):1059–68.CrossRefPubMed
74.
Scholzel-Dorenbos CJM, Arons AMM, Wammes JJG, Rikkert MGMO, Krabbe PFM. Validation study of the prototype of a disease-specific index measure for health-related quality of life in dementia. Health Qual Life Outcomes. 2012;10:118.CrossRefPubMedPubMedCentral
75.
Shaw RW, Brickley MR, Evans L, Edwards MJ. Perceptions of women on the impact of menorrhagia on their health using multi-attribute utility assessment. Br J Obstet Gynaecol. 1998;105(11):1155–9.CrossRefPubMed
76.
Stevens KJ, Brazier JE, McKenna SP, Doward LC, Cork MJ. The development of a preference-based measure of health in children with atopic dermatitis. Br J Dermatol. 2005;153(2):372–7.CrossRefPubMed
77.
Stevens K, Palfreyman S. The use of qualitative methods in developing the descriptive systems of preference-based measures of health-related quality of life for use in economic evaluation. Value Health. 2012;15(8):991–8.CrossRefPubMed
78.
79.
Stolk EA, Busschbach JJV. Validity and feasibility of the use of condition-specific outcome measures in economic evaluation. Qual Life Res. 2003;12(4):363–71.CrossRefPubMed
80.
Sundaram M, Smith MJ, Revicki DA, Elswick B, Miller LA. Rasch analysis informed the development of a classification system for a diabetes-specific preference-based measure of health. J Clin Epidemiol. 2009;62(8):845–56.CrossRefPubMed
81.
Sundaram M, Smith MJ, Revicki DA, Miller LA, Madhavan S, Hobbs G. Estimation of a valuation function for a diabetes mellitus-specific preference-based measure of health: the Diabetes Utility Index. PharmacoEconomics. 2010;28(3):201–16.CrossRefPubMed
82.
Versteegh MM, Leunis A, Uyl-de Groot CA, Stolk EA. Condition-specific preference-based measures: benefit or burden? Value Health. 2012;15(3):504–13.CrossRefPubMed
83.
Young T, Yang Y, Brazier JE, Tsuchiya A, Coyne K. The first stage of developing preference-based measures: constructing a health-state classification using Rasch analysis. Qual Life Res. 2009;18(2):253–65.CrossRefPubMed
84.
Yang Y, Brazier J, Tsuchiya A, Coyne K. Estimating a preference-based single index from the overactive bladder questionnaire. Value Health. 2009;12(1):159–66.CrossRefPubMed
85.
Desroziers K, Aballéa S, Maman K, Nazir J, Odeyemi I, Hakimi Z. Estimating EQ-5D and OAB-5D health state utilities for patients with overactive bladder. Health Qual Life Outcomes. 2013;11:200.CrossRefPubMedPubMedCentral
86.
Kharroubi SA, Brazier J, Yang Y. Modeling a preference-based index for two condition-specific measures (asthma and overactive bladder) using a nonparametric Bayesian method. Value Health. 2014;17(4):406–15.CrossRefPubMed
87.
Young TA, Rowen D, Norquist J, Brazier JE. Developing preference-based health measures: using Rasch analysis to generate health state values. Qual Life Res. 2010;19(6):907–17.CrossRefPubMed
88.
Young TA, Yang Y, Brazier JE, Tsuchiya A. The use of Rasch analysis in reducing a large condition-specific instrument for preference valuation: the case of moving from AQLQ to AQL-5D. Med Decis Mak. 2011;31(1):195–210.CrossRef
89.
Yang YL, Brazier JE, Tsuchiya A, Young TA. Estimating a preference-based index for a 5-dimensional health state classification for asthma derived from the Asthma Quality of Life Questionnaire. Med Decis Mak. 2011;31(2):281–91.CrossRef
90.
Alava MH, Brazier J, Rowen D, Tsuchiya A. Common scale valuations across different preference-based measures: estimation using rank data. Med Decis Mak. 2013;33(6):839–52.
91.
McTaggart-Cowan HM, Marra CA, Yang Y, Brazier JE, Kopec JA, FitzGerald JM, et al. The validity of generic and condition-specific preference-based instruments: the ability to discriminate asthma control status. Qual Life Res. 2008;17(3):453–62.CrossRefPubMed
92.
Hedayat A, Sloane N, Stufken J. Orthogonal arrays: theory and applications. New York: Springer; 1999.CrossRef
93.
Hagquist C, Bruce M, Gustavsson J. Using the Rasch model in nursing research: an introduction and illustrative example. Int J Nurs Stud. 2009;46:380–93.CrossRefPubMed
94.
Tennant A, Conaghan P. The Rasch measurement model in rheumatology: what is it and why use it? When should it be applied, and what should one look for in a Rasch paper? Arthritis Rheum. 2007;57(8):1358–62.CrossRefPubMed
95.
O’Connor R. Measuring quality of life in health. Edinburgh: Churchill Livingstone; 2004.
96.
NICE. Guide to the methods of technology appraisal 2013. National Institute for Health and Care Excellence; 2013.
97.
Feeny D. The utility approach to assessing population health. In: Murray C, Salomon J, Mathers C, Lopez A, editors. Summary measures of population health: concepts, ethics, measurement and applications. Geneva: World Health Organisation; 2002. p. 515–28.
98.
Dolan P. Modelling the relationship between the description and valuation of health states. In: Murray C, Salomon J, Mathers C, Lopez A, editors. Summary measures of population health: concepts, ethics, measurement and applications. Geneva: World Health Organisation; 2002. p. 501–14.
99.
Drummond M, Sculpher M, Torrance G, O’Brien B, Stoddart G. Methods for the economic evaluation of health care programmes. 3rd ed. Oxford: Oxford University Press; 2005.
Metadata
Title
A Systematic Review of the Literature on the Development of Condition-Specific Preference-Based Measures of Health
Authors
Elizabeth Goodwin
Colin Green
Publication date
01-04-2016
Publisher
Springer International Publishing
Published in
Applied Health Economics and Health Policy / Issue 2/2016
Print ISSN: 1175-5652
Electronic ISSN: 1179-1896
DOI
https://doi.org/10.1007/s40258-015-0219-9

Other articles of this Issue 2/2016

Applied Health Economics and Health Policy 2/2016 Go to the issue

Letter to the Editor

Authors’ Reply to Gandjour: “The Role of Chronic Disease, Obesity, and Improved Treatment and Detection in Accounting for the Rise in Healthcare Spending Between 1987 and 2011”

Scoping Review

A Scoping Review of Healthcare Costs for Patients with Cystic Fibrosis

Current Opinion

The Missing Stakeholder Group: Why Patients Should be Involved in Health Economic Modelling

Original Research Article

The Long-Term Cost to the UK NHS and Social Services of Different Durations of IV Thiamine (Vitamin B1) for Chronic Alcohol Misusers with Symptoms of Wernicke’s Encephalopathy Presenting at the Emergency Department

Systematic Review

The Cost Effectiveness of High-Dose versus Conventional Haemodialysis: a Systematic Review

Book Review

A Review of “The New Drug Reimbursement Game: A Regulator’s Guide to Playing and Winning”